ViaCyte proposes stem cell implant to address type 1 diabetes

05/31/2011 | Los Angeles Times (tiered subscription model)

San Diego-based ViaCyte has proposed implanting a pouch filled with pancreatic cells under the skin to help reduce insulin dependence among patients with type 1 diabetes. The firm tested the procedure to treat diabetes in mice and hopes to initiate human trials in patients by 2013.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL